NA

Naresh Anamalla

Director Director DIN 08506538
DIN 08506538 First appointment Feb 2013 Primary industry Construction
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Naresh Anamalla

Data last updated:

Naresh Anamalla was a Director at Mega Avenues Private Limited (2013–2014) and Director at Acierto Pharmaceuticals Private Limited (from 2019). The companies operate in Construction.

DIN 08506538
Primary Designation Director
Industry Construction
First Appointment 23 Feb 2013
Oldest Company Age 7 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mega Avenues Private Limited U45209TG2012PTC083737
Director23 Feb 20132012Active
Director10 Jul 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Acierto Pharmaceuticals Private Limited
Mega Avenues Private Limited
Premium access

Shareholding and investment profile for Naresh Anamalla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naresh Anamalla

Naresh Anamalla was first appointed on 23 Feb 2013 as Director at Mega Avenues Private Limited. The most recent appointment on record is 10 Jul 2019 at Acierto Pharmaceuticals Private Limited.

Naresh Anamalla held 2 earlier board appointments: Mega Avenues Private Limited (Director, 23 Feb 2013 to 27 Jan 2014); Acierto Pharmaceuticals Private Limited (Director, from 10 Jul 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available